Inactive Instrument

Think Research Corporation

THNK

CA88410J1075

Software

Delayed Toronto S.E. Other stock markets 11:10:54 2024-04-22 EDT			5-day change	1st Jan Change
0.315 ^CAD	-.--%		-.--%	+65.79%

04-18	Beedie Capital completed the acquisition of remaining 96.27551% stake in Think Research Corporation (TSXV : THNK) from shareholders.	CI
04-04	Transcript : Think Research Corporation - Shareholder/Analyst Call

Think Research Corporation Provides Earnings Guidance for the Year 2023

May 01, 2023 at 07:10 am

Think Research Corporation provided earnings guidance for the year 2023. For fiscal year 2023 revenue pipeline is robust, with significant revenue growth potential existing in the Canadian market and internationally.

Latest news about Think Research Corporation

Beedie Capital completed the acquisition of remaining 96.27551% stake in Think Research Corporation (TSXV : THNK) from shareholders.	04-17	CI
Transcript : Think Research Corporation - Shareholder/Analyst Call	04-04
Think Research Says No Alternative Buyers Emerge as Shareholder Vote Next Week on Going Private Transaction	03-26	MT
Think Research Brief: Co Says "Now subject to a non-solicitation covenant with customary "fiduciary out" provisions Under Terms of the Arrangement Agreement	03-26	MT
Think Research Brief: Providing Update on Going Private Transaction; "Go-shop" Period Expired on March 16, 2024, With No Acquisition Proposal Having Been Received	03-26	MT
Think Research Corp. Provided a Financial Update	03-06	MT
Think Research Announces $5.0 Million Contract Expansion with a Global Pharmaceutical Company	02-21	CI
Think Research Agrees to be Bought by Beedie Capital; Up 87.5%	02-16	MT
Think Research Agrees to be Bought by Beedie Capital	02-16	MT
Think Research Brief: Shareholders to receive cash payment of $0.32 per Common Share	02-16	MT
Think Research Brief: Entering into Definitive Agreement to be Acquired by Beedie Capital	02-16	MT
Beedie Capital entered into an arrangement agreement to acquire remaining stake in Think Research Corporation (TSXV : THNK) from shareholders.	02-15	CI
Think Research Secures $1 Million Subsequent Advance Under Existing Convertible Facility; Up 7%	01-19	MT
Think Research Secures $1 Million Subsequent Advance Under Existing Convertible Facility	01-19	MT
Think Research's Learning Management System to Support Healthcare Professional Education and Training	12-07	CI
Transcript : Think Research Corporation, Q3 2023 Earnings Call, Nov 27, 2023	11-27
Think Research Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-27	CI
Think Research Corporation Appoints Jeffrey Orridge to Its Board of Directors	23-10-20	CI
Major Long-Term Care Pharmacy Selects Think Research Corporation's Pharmapod to Enhance Medication Safety	23-10-05	CI
Think Research Announces Agreement For Advance Under Convertible Facility	23-09-29	MT
Think Research Corporation Announces Technology Partner Supporting Ontario Ministry of Health's One Stop Talk/Parlons Maintenant Service for Child and Youth Mental Health	23-09-12	CI
Think Research Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-29	CI
Transcript : Think Research Corporation, Q2 2023 Earnings Call, Aug 29, 2023	23-08-29
Think Research Corporation Announces Bridge Loan	23-08-17	CI
Think Research Detailed Bridge Loan	23-08-17	MT

Chart Think Research Corporation

Duration

Period

More charts

Company Profile

Think Research Corporation is a Canada-based company engaged in delivering knowledge-based digital health software solutions. The Companyâs evidence-based healthcare technology solutions support the clinical decision-making process and standardization of care to facilitate better health care outcomes. It gathers, develops, and delivers knowledge-based solutions globally to customers, including enterprise clients, hospitals, health regions, healthcare professionals, and / or governments. The Company licenses its solutions to over 14,200 facilities for over 320,000 primary care, acute care, and long-term care doctors, nurses and pharmacists that rely on the content and data provided by the Company to support their practices. In addition, the Company collects and manages pharmaceutical and clinical trial data via its BioPharma Services subsidiary. The Companyâs other services include a network of digital-first primary care clinics and medical clinics that provide elective surgery.

Sector

Software

Calendar

2024-05-26 - Q1 2024 Earnings Release (Projected)

More about the company

Sector Other Software

	1st Jan change	Capi.
MICROSOFT CORPORATION	+11.75%	3,123B
SYNOPSYS INC.	+10.06%	86.45B
CADENCE DESIGN SYSTEMS, INC.	+6.04%	78.6B
DASSAULT SYSTÈMES SE	-14.66%	53.98B
PALANTIR TECHNOLOGIES INC.	+26.73%	48.46B
ATLASSIAN CORPORATION	-24.44%	46.78B
THE TRADE DESK, INC.	+31.74%	46.36B
SEA LIMITED	+82.12%	42.36B
TAKE-TWO INTERACTIVE SOFTWARE, INC.	-8.15%	25.25B

Other Software